Save time and get answers to complex questions with AI chat
Mebendazole ingredients?Dabrafenib btd date 2023?When will a generic version of xiaflex be available?Tracleer online pharmacy?Bortezomib market france?
See the DrugPatentWatch profile for tudorza
Yes. Tudorza (aclidinium bromide) is approved as a maintenance inhaler for chronic obstructive pulmonary disease (COPD), intended to help control symptoms and reduce flare-ups [1].
Tudorza is a long-term (maintenance) bronchodilator therapy. It helps open the airways so people with COPD can breathe more easily [1].
Tudorza comes in the Pressair inhaler device form (aclidinium bromide). That’s the product name associated with the approved COPD indication for this medication [1].
If you’re looking up patent or exclusivity details for aclidinium bromide (Tudorza), DrugPatentWatch tracks those filings and related information [1]. Sources: [1] https://www.drugpatentwatch.com/p/tradtiv-tudorza-iclidinium-bromide-patents
Other Questions About Tudorza :